| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
6,228 |
5,624 |
$1.97M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,784 |
5,368 |
$1.03M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,366 |
5,893 |
$867K |
| G0378 |
Hospital observation service, per hour |
9,283 |
3,404 |
$712K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,623 |
2,426 |
$631K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
8,872 |
2,728 |
$567K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
6,490 |
4,704 |
$351K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,834 |
2,645 |
$291K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
6,136 |
1,981 |
$187K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,505 |
2,326 |
$175K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
355 |
333 |
$159K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
640 |
597 |
$123K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
83 |
80 |
$75K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
631 |
290 |
$72K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
1,255 |
417 |
$51K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,384 |
755 |
$47K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
410 |
374 |
$20K |
| 97161 |
|
1,517 |
1,393 |
$19K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
353 |
330 |
$17K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
35 |
34 |
$12K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
623 |
344 |
$9K |
| 97535 |
Self-care/home management training, each 15 minutes |
772 |
533 |
$7K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
832 |
443 |
$6K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,317 |
5,061 |
$6K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
7,044 |
6,356 |
$6K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
9,031 |
7,223 |
$6K |
| 80053 |
Comprehensive metabolic panel |
10,482 |
7,786 |
$4K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
110 |
103 |
$2K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,896 |
1,700 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
560 |
512 |
$2K |
| 96376 |
|
3,988 |
2,312 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
9,632 |
7,237 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
14,970 |
11,951 |
$1K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,260 |
1,181 |
$1K |
| 71045 |
Radiologic examination, chest; single view |
5,217 |
4,695 |
$1K |
| 84484 |
|
6,504 |
4,285 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,829 |
2,232 |
$1K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,093 |
1,054 |
$1K |
| 97165 |
|
45 |
40 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
7,933 |
5,928 |
$724.70 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,489 |
1,342 |
$662.27 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,395 |
2,385 |
$551.65 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
52 |
37 |
$421.03 |
| 80306 |
|
1,392 |
1,303 |
$408.36 |
| 81001 |
|
7,299 |
6,524 |
$393.82 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
4,854 |
3,843 |
$374.85 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,833 |
3,189 |
$344.60 |
| 83690 |
|
4,663 |
4,096 |
$313.15 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,898 |
2,746 |
$285.14 |
| 81025 |
|
1,976 |
1,848 |
$277.10 |
| 87040 |
|
1,149 |
583 |
$240.17 |
| 94760 |
|
6,067 |
2,749 |
$231.08 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
122 |
38 |
$189.90 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
4,355 |
3,952 |
$182.90 |
| J2060 |
Injection, lorazepam, 2 mg |
1,725 |
1,214 |
$175.59 |
| 83735 |
|
3,879 |
2,454 |
$172.15 |
| 82248 |
|
3,797 |
3,406 |
$153.07 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
131 |
119 |
$149.96 |
| 85730 |
|
1,168 |
1,037 |
$149.34 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,307 |
2,094 |
$146.53 |
| 85379 |
|
1,369 |
1,243 |
$140.19 |
| 97116 |
|
237 |
108 |
$123.72 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,542 |
2,306 |
$117.66 |
| 84703 |
|
2,445 |
2,288 |
$106.51 |
| 36415 |
Collection of venous blood by venipuncture |
5,829 |
4,272 |
$105.87 |
| 83605 |
|
1,166 |
950 |
$97.86 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,912 |
969 |
$97.26 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
804 |
560 |
$94.77 |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,097 |
1,020 |
$86.80 |
| J2704 |
Injection, propofol, 10 mg |
3,353 |
2,895 |
$83.87 |
| 82962 |
|
5,506 |
2,148 |
$81.77 |
| 82550 |
|
588 |
460 |
$77.13 |
| 83880 |
|
681 |
590 |
$76.47 |
| 85027 |
|
4,981 |
3,231 |
$71.29 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
317 |
227 |
$71.18 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
3,105 |
2,583 |
$60.74 |
| 87186 |
|
389 |
317 |
$58.50 |
| 85610 |
|
3,332 |
2,880 |
$58.20 |
| 87077 |
|
558 |
442 |
$47.59 |
| 86900 |
|
67 |
64 |
$31.82 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
12 |
12 |
$24.94 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
12 |
12 |
$24.86 |
| 80329 |
|
436 |
277 |
$24.22 |
| 80320 |
|
1,657 |
1,477 |
$24.22 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,883 |
2,586 |
$22.74 |
| 84100 |
|
494 |
347 |
$22.61 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
787 |
694 |
$22.53 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,501 |
954 |
$18.97 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
14 |
14 |
$13.51 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
21 |
21 |
$12.49 |
| A9270 |
Non-covered item or service |
2,551 |
291 |
$12.02 |
| J7050 |
Infusion, normal saline solution, 250 cc |
93 |
48 |
$5.08 |
| 87205 |
|
146 |
126 |
$3.57 |
| 84132 |
|
391 |
273 |
$3.44 |
| J3490 |
Unclassified drugs |
100 |
67 |
$2.17 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,240 |
789 |
$0.00 |
| C1769 |
Guide wire |
560 |
470 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
162 |
147 |
$0.00 |
| 87070 |
|
55 |
50 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,982 |
1,410 |
$0.00 |
| 93971 |
|
71 |
64 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
402 |
223 |
$0.00 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
14 |
14 |
$0.00 |
| 86901 |
|
107 |
100 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
87 |
72 |
$0.00 |
| 88342 |
|
75 |
68 |
$0.00 |
| 86140 |
|
87 |
77 |
$0.00 |
| 87081 |
|
17 |
13 |
$0.00 |
| 85652 |
|
41 |
38 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
25 |
12 |
$0.00 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
15 |
12 |
$0.00 |
| 87400 |
|
292 |
137 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
571 |
453 |
$0.00 |
| 80061 |
Lipid panel |
72 |
66 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
92 |
82 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
719 |
443 |
$0.00 |
| 99152 |
|
89 |
81 |
$0.00 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
270 |
242 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
38 |
14 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
30 |
24 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
18 |
14 |
$0.00 |
| 81003 |
|
13 |
12 |
$0.00 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
26 |
26 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
15 |
12 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
75 |
37 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
26 |
25 |
$0.00 |
| 96367 |
|
13 |
13 |
$0.00 |